Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN108570014A details high-yield chiral morpholine synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115677605A reveals a mild 5-step route for S-Fluralaner. Achieve higher ee values and yields with cost-effective chiral thiourea catalysis for veterinary markets.
Patent CN104327073A details a safer vinpocetine synthesis eliminating column chromatography. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Novel cyclic phosphine catalyst Le-Phos enables high-yield asymmetric gamma-addition. Efficient synthesis route reduces costs for API manufacturing.
Patent CN116693653A reveals advanced solid-liquid phase synthesis for Somalupeptide. Enhances purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN101787032A reveals a cost-effective clopidogrel synthesis using D-camphorsulfonic acid resolution, offering high purity and scalable manufacturing for global supply chains.
Patent CN102675216B details a novel purification process for 4,6-dichloropyrimidine, offering higher purity and yield for pharmaceutical intermediates manufacturing.
Novel catalytic process for Vortioxetine intermediate ensures high purity and cost efficiency. Reliable supply chain solution for global pharmaceutical manufacturing partners.
Patent CN105646319B reveals a column-free synthesis route for Brivaracetam, enabling cost reduction in API manufacturing and high-purity output suitable for commercial scale-up.
Advanced synthesis of stable isotope labeled tauryl amine hydrochloride via CN114539106A. Delivers >98% isotopic abundance and >99% purity for pharmacokinetic research.
Discover the novel synthesis of Ketorolac Tromethamine Intermediate VI via patent CN113087626A. Achieve higher purity, reduced waste, and scalable manufacturing for global supply chains.
Patent CN107417615A enables high-purity quinolinone manufacturing via visible light catalysis. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Novel ruthenium complex synthesis patent CN105440085A offers high purity and selectivity for antitumor drug manufacturing supply chain efficiency.
Patent CN107417615A enables visible light promoted synthesis of chiral quinolinone derivatives. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN115010686A details a novel resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one, offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Novel patent CN114031659A details a scalable route for Levonorgestrel Impurity O, offering cost-effective production and high purity for global pharmaceutical supply chains.
Stable chiral intermediate synthesis via CN109851542A. Enhanced storage stability and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN1159320C reveals a novel onium salt route for cefepime. Achieve cost reduction in pharmaceutical intermediates manufacturing with high-purity scalable methods.
Patent CN109206354A details a one-step carbonylation method for N-(1-naphthyl)phthalimide. This breakthrough offers mild conditions and excellent yield for supply chain optimization.
Novel patent CN114845991B eliminates ethylene oxide risks. Enhances supply chain safety and cost reduction in API manufacturing significantly.